Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
In published trials the Tirzepatide is a once-weekly peptide that activates two receptors, GIP and GLP-1, and it is sold by Eli Lilly as Mounjaro for type 2 diabetes and Zepbound for chronic weight manag Retatrutide (development code LY3437943, often shortened to GLP-3 in community shorthand) is a single peptide that activates three receptors at once: GLP-1, GIP and Get our latest evidence-based peptide articles as they publish
For clinical notes (NOTEEVENTS.csv), we used the R library tm 46 by following a simple pipeline
2.MOQ: 1g or 5g 3.More than 4.More than 5.Certification: 6.Lead time:about 8-12 working days
Inflammation of the pancreas (pancreatitis): severe stomach pain that might spread to your back, nausea, vomiting, fever Dangerously low blood sugar: feeling hungry, fast heartbeat, shakiness, anxiety, sweating, tingling, dizziness, weakness, drowsiness, confusion Kidney damage: nausea, vomiting, trouble urinating, muscle cramps, feeling confused, swelling in the ankles or feet, trouble breathing Gallbladder problems: pain in the upper right side of the stomach, nausea, vomiting Serious allergic reaction: hives
US$ 29.61
US$ 20.12
US$ 25.04
US$ 28.77
US$ 26.27
US$ 28.53
US$ 24.19
